Answers are grounded in this paper and cite their sources.
This analysis develops a scoring tool to improve interpretation of MOG antibodies in MOGAD, suggesting better clinical accuracy.
Myelin oligodendrocyte glycoprotein (MOG) antibodies (MOG-IgG) are a biomarker of MOG antibody-associated disease (MOGAD). However, false positives remain common. We aimed to develop a scoring tool to guide interpretation.
No takes yet. Share an insight, caveat, or question.
Vilaseca et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: